Workflow
赛升药业: 关于公司向金融机构申请综合授信并为子公司提供担保的公告

Overview of Credit and Guarantee Situation - The company has approved a comprehensive credit application not exceeding 200 million yuan, with a guarantee of 100 million yuan for its subsidiary, Shenyang Junyuan Pharmaceutical Co., Ltd. [1] - The board of directors approved this decision to support the operational and future development needs of the company and its subsidiary [1]. Progress of Guarantee - The subsidiary Junyuan Pharmaceutical has applied for a financing loan from China Everbright Bank Luxembourg Branch, and the company has signed a contract with Hangzhou Bank Beijing Branch for a guarantee [2]. - The company applied for a comprehensive credit limit of 100 million yuan from Hangzhou Bank, utilizing 21.09989 million yuan for a financing guarantee, benefiting Everbright Bank Luxembourg Branch [2]. Main Contents of Guarantee Contract and Loan Agreement - The guarantee amount for the external guarantee/standby letter of credit contract is USD 2.95 million, with a guarantee expiration date of June 18, 2026 [2][3]. - The loan agreement specifies that the borrower is Shenyang Junyuan Pharmaceutical Co., Ltd., with a loan amount of USD 2.8 million for daily operational needs [3]. Cumulative External Guarantee Situation - As of the announcement date, the total approved external guarantee amount is 21.09989 million yuan, accounting for 0.61% of the company's latest audited net assets [3]. - The company has no overdue guarantees and does not provide guarantees for non-affiliated parties or those involved in litigation [3].